The Quit 7-OH plan includes five doctor visits for $79 each and structured clinical support, including personalized discussions about tapering when appropriate.

LOS ANGELES, September 1, 2026 — QuickMD, one of the largest direct-to-consumer telemedicine platforms in the U.S., announced the launch of its Quit 7-OH Plan today, a new option designed for people who want medical support to reduce or stop their use of 7-hydroxymitragynine (7-OH) or kratom.

The launch comes amid federal action on concentrated 7-OH products. In July, the Drug Enforcement Administration published a notice of intent to temporarily place 7-OH and related substances into Schedule I of the Controlled Substances Act. The action targets certain products containing elevated concentrations of 7-OH and does not apply to botanical kratom containing naturally occurring 7-OH below the threshold established by the DEA.

QuickMD doctors have completed more than 30,000 visits focused on helping people quit 7-OH and kratom. In caring for these patients, QuickMD has found that many want to stop using 7-OH as quickly as possible and frequently ask whether they can use Suboxone® to manage withdrawal and then taper off. Some patients complete an initial visit and then attempt to manage that process themselves, including by following tapering schedules and advice found online.

The Quit 7-OH Plan is designed to keep a doctor involved. For $395, Quit 7-OH Plan patients receive five doctor visits at $79 per visit. The visits give patients a structured way to manage withdrawal and cravings, evaluate how treatment is progressing and discuss what comes next, including whether tapering may eventually be appropriate.

“We hear from patients every day who want to know, ‘Can you help me quit, and can I eventually get off the medication?’” said Dr. Robert Stern, M.D., Chief Medical Officer of QuickMD. “Those are reasonable questions, but the answer should not come from a taper someone found online. Tapering can be appropriate for some patients, but not everyone, and there is no single schedule that is right for every person. That decision should be made with a clinician based on how the patient is responding to treatment.”

Each patient receives an individual clinical assessment based on their symptoms, medical history and patterns of use. When clinically appropriate, treatment may include medications such as buprenorphine-naloxone (also known by the brand name Suboxone®) to help manage withdrawal and cravings. As patients stabilize, they can continue working with their doctor to determine the appropriate next step. For some, that may include gradually tapering medication under clinical supervision. For others, remaining on medication or taking a different treatment approach may be more appropriate.

The Quit 7-OH Plan is not a five visit Suboxone taper and does not promise that a patient will stop medication within a particular timeframe. Research specific to treating 7-OH and kratom dependence remains limited, and there is no established tapering approach that works for everyone. Most patients are encouraged to use the five visits over approximately four months depending on how treatment is progressing. If additional care is appropriate after the five visits, Quit 7-OH Plan patients can continue their treatment through QuickMD’s addiction treatment plan at $99 per visit.

“The concern is not that patients are asking about tapering. It is that many are trying to figure out how to do it alone,” said Ryan Lissack, Chief Executive Officer of QuickMD. “We want patients to bring that goal to a doctor instead of relying on a schedule they found online. The goal is to give patients a clear, affordable path to stay connected to clinical care while they work toward quitting.”

QuickMD provides private, nonjudgmental addiction treatment through secure phone and video visits. Same-day visits are often available seven days a week, with no insurance or referral required. QuickMD’s addiction treatment services are available in 44 states and Washington, D.C.

Adults seeking help quitting 7-OH or kratom can learn more about the Quit 7-OH Plan at QuickMD.com.

About QuickMD

QuickMD is one of the largest direct-to-consumer telemedicine platforms in the U.S., with more than 1.5 million patient visits completed. The company specializes in Medication-Assisted Treatment (MAT) for opioid use disorder and 7-OH and kratom dependence, and also offers women’s hormone therapy, mental health care, weight management, and urgent care. Through its nationwide network of experienced clinicians, QuickMD helps patients get care quickly, wherever they are.

Media contact

Jacob Ehrlich
VP, Marketing
jacob@quick.md